Introducing Drapalin Pharmaceuticals GmbH – a german pharmaceutical company which is specialises in medical cannabis.
DRAPALIN is a globally oriented company with a vertically integrated structure that controls the entire life cycle of the cannabis product – from cultivation to processing to distribution.
Their main goal is to gain a high level of trust in the medical community and to promote the well-being of patients in Germany.
With the support of DRAPALIN, MG Health was the first African company ever to be recognized as a manufacturer of non-irradiated medical cannabis in Germany in accordance with the EU GMP guidelines. This also means secured quality and production standards in the field of standardized medical plant cultivation and production – one of the requirements for exporting the product to Europe.